Silverarc Capital Management’s Xenon Pharmaceuticals XENE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$11.5M	Buy	+197,759	New	+$9.11M	1.36%	24
2025 Q2	–	Sell	-10,121	Closed	-$340K	–	91
2025 Q1	$340K	Buy	+10,121	New	+$384K	0.07%	65
2024 Q2	–	Sell	-66,090	Closed	-$2.85M	–	90
2024 Q1	$2.85M	Sell	66,090 -97,078	-59%	-$4.47M	0.8%	38
2023 Q4	$7.52M	Buy	163,168 +109,172	+202%	+$3.86M	2.32%	16
2023 Q3	$1.84M	Sell	53,996 -45,760	-46%	-$1.71M	0.69%	48
2023 Q2	$3.84M	Buy	99,756 +3,113	+3%	+$124K	1.3%	29
2023 Q1	$3.46M	Sell	96,643 -157,012	-62%	-$5.8M	1.55%	27
2022 Q4	$10M	Buy	253,655 +7,663	+3%	+$279K	3.44%	6
2022 Q3	$8.88M	Buy	245,992 +13,362	+6%	+$480K	3.77%	10
2022 Q2	$7.08M	Buy	232,630 +131,549	+130%	+$3.98M	3.32%	16
2022 Q1	$1.43K	Buy	101,081 +1,081	+1%	+$32.4K	0.68%	43
2021 Q4	$3.12M	Buy	100,000 +80,568	+415%	+$2.41M	1.4%	27
2021 Q3	$297K	Buy	+19,432	New	+$338K	0.17%	77